Annolyse
BriefingsCompaniesScreenerInsightsPrinciplesCompareChatWatchlist

Explore

  • Briefings
  • Companies
  • Screener
  • Insights
  • Compare

Resources

  • Search
  • Methodology

© 2026 Annolyse.

←Back to companies

DGL · NZX

Delegat Group (DGL)

Consumer / Wine and beverages•Covered: HY24 - HY26•5 published briefings

Delegat Group is an NZX-listed consumer / wine and beverages company with HY24 - HY26 of published result briefings.

Latest briefing

HY26 · Released 27 February 2026

PBT up 85.1% but Operating EBIT only +5% on flat revenue

Headline earnings growth far outstrips underlying volume and revenue gains, with the lift coming from below-EBIT items rather than trading.

Market data

As at close
Close price
NZD 4.02
Market cap
$406.5m
Dividend yield
5%

as at close, 19 June 2026. Source: yfinance.

Sections⌄
  1. Snapshot
  2. Valuation
  3. Chat
  4. Longitudinal View
  5. Follow-through
  6. Archive
  7. Related Insights
  1. Snapshot
  2. Valuation
  3. Chat
  4. Longitudinal View
  5. Follow-through
  6. Archive
  7. Related Insights

Snapshot

Latest metrics

HY26, released 27 February 2026

← Swipe to view more
DGL latest metrics
MetricValueChange
Revenue$179.6m↑ +0.5%
EBITDA$65.6m↑ +6.4%
NPAT$22.8m↑ +82.4%
Operating cash flow$62.3m↓ -17.5%
OCF / EBITDA %95.0%↓ -27.6pp
Net debt$307m↓ -11.2%
Net debt / EBITDA4.68x↓ -16.6%
ROE %3.9%↑ +1.6pp
DPS579.0c↑ +7.4%
PBT$32.2m↑ +85.1%

Source: latest published briefing (HY26, released 27 February 2026). Change compares against the prior equivalent period: HY25, released 28 February 2025.

Valuation

Valuation

A compact read on what the market price implies next to the latest filing data. The numbers are a starting point for comparison, not a recommendation.

Prices as at close, 19 June 2026

Price and market cap

The latest close and share count context for the market price.

Market cap

$406.5m

i

End-of-day close multiplied by current shares on issue.

Profitability multiples

How the market price compares with recent earnings and cash-flow inputs.

P/E

6.86x

i

Recent market cap compared with trailing earnings.

EPS

0.59

i

Recent filing-derived earnings per share.

PEG

0.08x

i

P/E compared with recent earnings growth.

EV/EBITDA

5.92x

i

Enterprise value compared with recent EBITDA.

P/FCF

5.57x

i

Market cap compared with recent free cash flow.

P/B

0.69x

i

Market value compared with latest reported equity.

Income and fund shape

Yield and fund-style valuation where the company shape supports it.

Dividend yield

5.0%

i

Trailing dividends compared with the latest close.

Total return

Not available

i

Available once dividend and adjustment data are verified.

Price history

Daily closes use the full available width, with hover and touch readouts against real observations. Expand opens the chart at reading size.

Share price

Five years of daily closes, as at close, 5 June 2026. Weekends, suspensions, and listing gaps stay as natural gaps in the time scale.

↗
Loading chart...

Price vs earnings

Indexed lines compare direction from the first positive comparable filing point. The axis is an index, not dollars or cents.

↗
Loading chart...

Chat

Ask about DGL

Ask follow-up questions about Delegat Group's latest result and company history.

Informational only. No buy, sell, hold, price-target, or personal financial advice.

Ask about DGL

Informational only. No buy, sell, hold, price-target, or personal financial advice.

Sign in to chat

Sign in to ask company questions.

What changed in the latest result?What is unusual in the historical context?How has cash conversion changed over time?Compare this company with CNU.

Checking account...

Longitudinal view

Performance over time

The latest period is shown first.

← Swipe to view more
DGL metric history
MetricHY266 MONTHS27 February 2026HY256 MONTHS28 February 2025FY2512 MONTHS3 February 2025FY2412 MONTHS7 August 2024HY246 MONTHS23 February 2024Trend
Revenue$179.6m$178.6m$349.6m$378.3m$203.1m
Chart
Revenue growth %0.5%-12.0%-7.6%-0.8%-2.9%
Chart
EBITDA$65.6m$61.6m$116.5m$128.5m$74.8m
Chart
EBITDA margin %36.5%34.5%33.3%34.0%36.8%
Chart
PBT$32.2m$17.4m$68.4m$61.6m$46.4m
Chart
PBT growth %85.1%-62.5%11.0%-31.4%-17.1%
Chart
NPAT$22.8m$12.5m$49m$31.4m$33.4m
Chart
NPAT growth %82.4%-62.6%56.1%-51.5%-17.9%
Chart
Operating cash flow$62.3m$75.6m$105.7m$56.9m$35.8m
Chart
OCF / EBITDA %95.0%122.6%90.7%44.2%47.8%
Chart
FCF pre-lease$51.8m$38.2m$59.3m-$9.1m-$9.1m
Chart
FCF post-lease————-$9.1m
—
DPS579.0c539.0c20.0c20.0c—
Chart
Payout ratio vs NPAT %——41.3%64.5%—
Chart
Annual payout ratio vs EPS %——41.2%64.5%—
Chart
ROE %3.9%2.3%8.4%5.6%6.0%
Chart
Net debt$307m$345.6m$328.6m$360.1m$352.3m
Chart
Net debt / EBITDA4.68x5.61x2.82x2.8x4.71x
Chart
Debtor days6170597477
Chart
Inventory days145140196176136
Chart
Total assets$1.1b$1.1b$1.1b$1.1b$1.1b
Chart

Reference: annolyse.ai/companies/dgl

Note: Figures are shown as reported. Half-year and full-year absolute values are not directly comparable. Growth rates and ratios are the meaningful comparison across mixed periods.

Filing-only history charts

These charts use verified published filing periods only. Gaps are not interpolated, and mixed half-year/full-year histories are split into separate series.

Revenue

Reported revenue across covered periods.

↗
Loading chart...

Revenue growth

Like-period revenue growth where comparable.

↗
Loading chart...

EBITDA-equivalent

Company-specific earnings measure where disclosed.

↗
Loading chart...

EBITDA margin

EBITDA-equivalent margin where revenue and earnings are source-backed.

↗
Loading chart...

NPAT

Statutory profit after tax.

↗
Loading chart...

Operating cash flow

Cash generated from operations.

↗
Loading chart...

Full chartable metric set

Additional verified filing metrics for this company. Each point links back to a published briefing period in the source data contract.

OCF / EBITDA

Cash conversion against earnings.

↗
Loading chart...

FCF pre-lease

Operating cash flow less capex before leases.

↗
Loading chart...

FCF post-lease

Free cash flow after lease payments where available.

↗
Loading chart...

ROE

Return on equity.

↗
Loading chart...

Net debt

Borrowings less cash; negative values indicate net cash.

↗
Loading chart...

Net debt / EBITDA

Leverage ratio, suppressed where earnings are not meaningful.

↗
Loading chart...

DPS

Dividend per share declared for the period.

↗
Loading chart...

Payout ratio

Dividend payout against statutory NPAT.

↗
Loading chart...

Debtor days

Receivables days where the working-capital inputs are source-backed.

↗
Loading chart...

Inventory days

Inventory days where the working-capital inputs are source-backed.

↗
Loading chart...

Operating working-capital movement

Per-period working-capital absorption or release, from the same published history. Positive values are working-capital build; negative values are release.

↗
Loading chart...

The setup & the reality

HY25 → HY26 Follow-through

The latest result is checked against what the prior briefing said to watch.

Current result now available

HY26 · Released 27 February 2026

PBT up 85.1% but Operating EBIT only +5% on flat revenue

Headline earnings growth far outstrips underlying volume and revenue gains, with the lift coming from below-EBIT items rather than trading.

Read latest briefing→

Historical setup

What HY25 said to watch

From NPAT fell 62.6% on volume weakness as cash flow doubled

No quantified FY25 target is supplied; the release excerpt referencing "FY25 Operating Net..." is truncated and cannot be relied on. The FY24 anchor period is also flagged as carrying a discontinued operation, which distorts any H1-to-FY share comparison: HY24 NPAT of $33.4m sat against FY24 NPAT of just $7.4m, implying an H2 loss in the prior year. That makes second-half shape inferences unreliable.

What the release does support: Delegat enters H2 with materially lower inventory and receivables, lower H1 capex, and a reduced earnings base. Whether H2 volumes recover in the USA and Europe is the central unknown; the result on its own does not speak to that.

Open questions

Open questions from HY25

  • What specifically is driving the 18.7% USA revenue decline — is it distributor destocking, shelf losses, or end-consumer demand softening?
  • Will the FY25 Operating NPAT guidance be quantified, and how does it bracket the H1 outturn?
  • How much further can inventory be drawn down before vintage replenishment requires a working-capital reinvestment in H2 or FY26?
  • Why is capex still running at 20.9% of revenue when volumes are contracting, and what is the path to free cash flow if working capital normalises?
  • Is the 5.39 cps interim dividend sustainable on a recurring-FCF basis if the working-capital release does not repeat?

This briefing cannot assess whether the H1 volume weakness reflects a temporary destocking cycle or a structural shift in premium wine demand, because the release provides no channel-level or end-consumer data.

Archive

Briefing archive

Every published Annolyse briefing for this company appears here in reverse chronological order.

HY26 · Released 27 February 2026

PBT up 85.1% but Operating EBIT only +5% on flat revenue

Headline earnings growth far outstrips underlying volume and revenue gains, with the lift coming from below-EBIT items rather than trading.

Read briefing→

HY25 · Released 28 February 2025

NPAT fell 62.6% on volume weakness as cash flow doubled

A $30.4m working-capital release lifted operating cash flow 111.3%, but earnings collapsed and trailing leverage rose to 5.6x EBITDA.

Read briefing→

FY25 · Released 3 February 2025

EBITDA fell $12m but NPAT rose as tax rate dropped to 28.3%

Operating EBITDA dropped to $116.5m on a 12% case-volume decline, with cash generation aided by a $19.9m debtor release and lower capex.

Read briefing→

FY24 · Released 7 August 2024

NPAT halved despite flat EBITDA as H2 swung to a loss

The effective tax rate jumped to 49.0%, receivable days extended from 51 to 74, and the held 20c dividend now consumes 64.5% of reported earnings.

Read briefing→

HY24 · Released 23 February 2024

NPAT fell 17.9% as working capital and capex pushed leverage to 4.7x

Flat EBITDA masked a sharp deterioration in cash deployment, with debtor days extending 20.7 and free cash flow turning negative.

Read briefing→

Related insights

Compare this company

The latest DGL metrics also appear in these cross-company views.

Insight

Cash conversion quality

This result converted 95.0% of EBITDA to operating cash flow, -27.6pp versus the prior comparable period.

Open insight→

Insight

Leverage and balance-sheet risk

Net debt / EBITDA is 4.70x, -0.90x versus the prior comparable period.

Open insight→

Insight

Working-capital pressure

Inventory days were 145 days, +5 days versus the prior comparable period.

Open insight→

Insight

Earnings quality and statutory distortions

PBT and NPAT growth diverged by 2.7pp.

Open insight→

Get notified when DGL publishes

Get the next Delegat Group result briefing and five-year history updates by email.